These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23239699)

  • 1. Can radiobiological parameters derived from squamous cell carcinoma of the head and neck be used to predict local control in anal cancer treated with chemoradiation?
    Pettit L; Meade S; Sanghera P; Glaholm J; Geh JI; Hartley A
    Br J Radiol; 2013 Jan; 86(1021):20120372. PubMed ID: 23239699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revised radiobiological modelling of the contribution of synchronous chemotherapy to the rate of grades 3-4 mucositis in head and neck cancer.
    Meade S; McConkey C; Sanghera P; Mehanna H; Hartley A
    J Med Imaging Radiat Oncol; 2013 Dec; 57(6):733-8; quiz 739-40. PubMed ID: 24283564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes after intensity-modulated compared with 3-dimensional conformal radiotherapy with chemotherapy for squamous cell carcinoma of the anal canal.
    Agarwal MS; Hitchcock KE; Morris CG; George TJ; Mendenhall WM; Zlotecki RA
    Curr Oncol; 2019 Aug; 26(4):e515-e521. PubMed ID: 31548820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Models of acute mucosal tolerance to radiotherapy alone applied to synchronous chemoradiation schedules in head and neck cancer.
    Meade S; Sanghera P; Glaholm J; Hartley A
    Tumour Biol; 2014 Mar; 35(3):2017-23. PubMed ID: 24104502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiobiological modelling of the therapeutic ratio for the addition of synchronous chemotherapy to radiotherapy in locally advanced squamous cell carcinoma of the head and neck.
    Hartley A; Sanghera P; Glaholm J; Mehanna H; McConkey C; Fowler J
    Clin Oncol (R Coll Radiol); 2010 Mar; 22(2):125-30. PubMed ID: 19880297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of the Primary Tumor in Anal Canal Cancers.
    Glynne-Jones R; Rao S
    Surg Oncol Clin N Am; 2017 Jan; 26(1):73-90. PubMed ID: 27889038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data.
    Szturz P; Wouters K; Kiyota N; Tahara M; Prabhash K; Noronha V; Castro A; Licitra L; Adelstein D; Vermorken JB
    Oncologist; 2017 Sep; 22(9):1056-1066. PubMed ID: 28533474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of locally advanced anal canal carcinoma with modulated arctherapy and concurrent chemotherapy].
    Troussier I; Huguet F; Servagi-Vernat S; Benahim C; Khalifa J; Darmon I; Ortholan C; Krebs L; Dejean C; Fenoglietto P; Vieillot S; Bensadoun RJ; Thariat J
    Cancer Radiother; 2015 Apr; 19(2):127-38. PubMed ID: 25770884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypofractionated chemoradiation for head and cancer: Data from the PET NECK trial.
    Vreugdenhil M; Fong C; Sanghera P; Hartley A; Dunn J; Mehanna H
    Oral Oncol; 2021 Feb; 113():105112. PubMed ID: 33321287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revised Modelling of the Addition of Synchronous Chemotherapy to Radiotherapy in Squamous Cell Carcinoma of the Head and Neck-A Low
    Best J; Fong C; Benghiat H; Mehanna H; Glaholm J; Hartley A
    Medicines (Basel); 2018 Jun; 5(2):. PubMed ID: 29899241
    [No Abstract]   [Full Text] [Related]  

  • 12. Altered fractionation outcomes for hypoxic head and neck cancer using the HYP-RT Monte Carlo model.
    Harriss-Phillips WM; Bezak E; Yeoh EK
    Br J Radiol; 2013 Apr; 86(1024):20120443. PubMed ID: 23392195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II/III Randomized Controlled Trial of Concomitant Hyperfractionated Radiotherapy plus Cetuximab (Anti-EGFR Antibody) or Chemotherapy in Locally Advanced Head and Neck Cancer.
    Al-Saleh K; El-Sherify M; Safwat R; Elbasmy A; Shete J; Hussein A; Nazeeh M; Bedair A
    Gulf J Oncolog; 2019 May; 1(30):6-12. PubMed ID: 31242976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer.
    Seiwert TY; Melotek JM; Blair EA; Stenson KM; Salama JK; Witt ME; Brisson RJ; Chawla A; Dekker A; Lingen MW; Kocherginsky M; Villaflor VM; Cohen EE; Haraf DJ; Vokes EE
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):21-9. PubMed ID: 27511844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulsed Radiation Therapy With Concurrent Cisplatin Results in Superior Tumor Growth Delay in a Head and Neck Squamous Cell Carcinoma Murine Model.
    Meyer K; Krueger SA; Kane JL; Wilson TG; Hanna A; Dabjan M; Hege KM; Wilson GD; Grills I; Marples B
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):161-9. PubMed ID: 27511853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of complex treatment of patients with squamous cell carcinoma of the anal canal using advanced radiotherapy technologies].
    Glebovskaya VV; Tkachev SI; Rasulov AO; Tsaryuk VF; Gordeev SS; Fedyanin MY; Aliev VA; Mamedly ZZ; Kuzmichev DV; Trofimova OP; Borisova TN; Yazhgunovich IP
    Vopr Onkol; 2015; 61(4):656-60. PubMed ID: 26571840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70-75 Gy in 5 weeks for advanced head and neck cancer. A phase I dose escalation study.
    Cvek J; Kubes J; Skacelikova E; Otahal B; Kominek P; Halamka M; Feltl D
    Strahlenther Onkol; 2012 Aug; 188(8):666-70. PubMed ID: 22648405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiotherapy for anal canal cancers].
    Peiffert D; Créhange G; Vendrely V; Baumann AS; Faivre JC; Huger S
    Cancer Radiother; 2016 Sep; 20 Suppl():S183-8. PubMed ID: 27523411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoradiotherapy for anal squamous cell carcinoma.
    Houlihan OA; O'Neill BD
    Surgeon; 2016 Aug; 14(4):202-12. PubMed ID: 27118047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.